Clinical Trials Sponsored by Cui xuejun

Total 752 results

Cui xuejun

Unknown

The Efficacy of the Traditional Chinese Medicine Fangji Huangqi Pill Combined With Mobic on Active Knee Osteoarthritis

Knee Osteoarthritis | Fangji Huangqi Pill

China
Cui xuejun

Unknown

Efficacy and Safety of HQGZWWT Patients With Rheumatoid Arthritis

Rheumatoid Arthritis | Huang Qi Gui Zhi Wu Wu Granule
Cui xuejun
Shanghai Yueyang Integrated Medicine Hospital; Longhua Hospital; Shanghai Seventh...

Unknown

The Efficacy of the Traditional Chinese Medicine Niubang Pill Combined With Methotrexate on Active Rheumatoid Arthritis

Rheumatoid Arthritis | Niu Bang Zi Pill

China
tiejun Zhang

Unknown

Effects of Different General Anesthesia Methods on Immune Responses in Patients Undergoing Surgery for Tongue Cancer

Tongue Cancer

China
Cui xuejun
Shanghai Yueyang Integrated Medicine Hospital; Shanghai Guanghua Hospital of... and other collaborators

Unknown

Juanbi Pill for Rheumatoid Arthritis

Rheumatoid Arthritis | Juanbi Pill

China
Junhui Cui
West China Hospital

Completed

A New Surgical Instrument in Treatment of Conlylar Fracture: Condylar Reductor

Mandibular Fracture
Xuekui Liu

Not yet recruiting

A Prospective, Single-arm Phase II Clinical Trial of Tislelizumab Combined With Platinum Doublet Neoadjuvant Therapy to Improve Mandibular Preservation in Resectable Locally Advanced Oral Squamous Cell Carcinoma. (B2023-153)

Oral Squamous Cell Carcinoma
Xuewen Wang

Completed

Snooze Control: Sleep Duration & Glucose Metabolism

Glucose Metabolism Disorders

United States
Xueqin Yang

Recruiting

RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC

NSCLC | Targeted Therapy | Evaluation

China
Xuekui Liu

Recruiting

Neoadjuvant Cadonilimab in Combination With Cisplatin and Nab-paclitaxel in Resectable Head and Neck Squamous Cell Carcinoma (NCCCNRHNSCC)

Head and Neck Squamous Cell Carcinoma | Locally Advanced Operable

China
Suzhou Kebo Ruijun Biotechnology Co., Ltd

Recruiting

A Clinical Study to Evaluate the Safety, Tolerability,JS019 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Xuekui Liu

Not yet recruiting

Cetuximab+Zimberelimab in Combination With Cisplatin and Nab-paclitaxel in Resctable Head and Neck Squamous Cell Carcinoma (CZCNRHNSCC)

Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable

China
Suzhou Kebo Ruijun Biotechnology Co., Ltd

Recruiting

A Phase 1 Study to Evaluate JS019 in Advanced Solid Tumors or Lymphomas

Advanced Solid Tumors or Lymphomas

China
Cui Yimin

Unknown

Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants

Pharmacokinetics | Pharmacodynamics | Apixaban | Pharmacogenomics | Accurate Medication | Rivaroxaban | Novel Oral Anticoagulants | NOACs | Dabigatran

China
Cui Yimin

Unknown

Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Ticagrelor

Pharmacokinetics | Pharmacodynamics | Pharmacogenomics | Accurate Medication | Ticagrelor

China
Cui Yimin

Unknown

Effect of Smoking Status and Genetic Risk Factors on Restenosis and Efficacy of Clopidogrel After de Novo Percutaneous Coronary Intervention

Coronary Heart Disease | Percutaneous Coronary Intervention | Restenosis | Clopidogrel | Smoking Status | Genetic Risk Factors

China
Cui Yimin

Unknown

Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

Pharmacokinetics | Drug-Related Side Effects and Adverse Reactions | Solid Tumors | Pharmacogenetics | Docetaxel

China
Cui Yimin

Unknown

miRNA and Relevant Biomarkers of BC Patients Undergoing Neoadjuvant Treatment

Breast Cancer

China
Sujun Zheng

Not yet recruiting

Research on the Clinical Characteristics and Key Diagnosis and Treatment Technology of Genetic and Metabolic Liver Disease

Diagnosis ， Treatment， Genetic and Metabolic Liver Disease
Cui Yimin

Unknown

A Research in Pharmacogenomics and Accurate Medication of Risperidone

Schizophrenia | Mental Illness

China
Cui Yimin

Unknown

Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

Solid Tumor | Pharmacokinetics | Drug-Related Side Effects and Adverse Reactions | Capecitabine | Pharmacogenetics

China
Cui Yimin

Unknown

A Pharmacogenomics Study of Simvastatin-Induced Adverse Drug Reaction

Simvastatin Adverse Reaction | Pharmacogenomics | Accurate Medication

China
Cui Yimin

Recruiting

Pharmacists' Intervention in Patients Using Novel Oral Anticoagulants：A Study on Behavioral Patterns

Behavioral Symptoms | Anticoagulants | Intention

China
Cui Yimin

Unknown

Evaluating Medication Adherence to Novel Oral Anticoagulants With Anticoagulant Activity Monitoring in Patients With Atrial Fibrillation

Compliance, Medication | Anticoagulants

China
Cui Yimin

Unknown

A Pharmacogenomics Study of Safety and Efficacy of Enalapril or Enalapril-Folic Acid Therapy in Hypertensive Patients.

Stroke | Pharmacogenomics | Enalapril Adverse Reaction

China
Fujun Zhang

Recruiting

Brachytherapy (Iodine-125 Seeds) and Fluzoparib Combination Therapy for Advanced Unresectable Soft Tissue Sarcoma (RAFAS-001)

Sarcoma,Soft Tissue | Brachytherapy | Poly(ADP-ribose) Polymerase Inhibitors

China
Jieqiong Cui

Not yet recruiting

A Clinical Study on the Effects of Inhalation of Volatile Oil of Cang-Ai Via the Nose on Patients With Depression

Depressive Disorder | Mental Disorder in Adolescence
Cui Xulei

Completed

Continuous Paravertebral Block on Postoperative Quality of Recovery After Hepatectomy

Nerve Block

China
Cui Xulei

Terminated

TMQLB Versus TPVB for Acute Pain and Quality of Recovery After Laparoscopic Renal Surgery

Nerve Block, Nephrectomy, Analgesia

China
Cui Xulei

Terminated

Continous Quadratus Lumborum Block for Hepatic Surgery With Right Subcostal Incision

Analgesia | Hepatectomy | Nerve Block

China
Cui Xulei

Completed

Thoracic Paravertebral Block : Effect on Acute Pain and Chronic Pain of Hepatectomy With Right J-shape Subcostal Incision

Analgesia | Hepatectomy | Nerve Block

China
YueJuan Cheng
NeoCura

Recruiting

Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors

Solid Tumor

China
Cui Xulei

Completed

Programmed Intermittent Bolus Infusion of Thoracic Paravertebral Block for Hepatectomy

Analgesia | Hepatectomy | Paravertebral Block | Postoperative Recovery

China
Cui Xulei

Completed

QLB Versus PVB for Acute Pain and Quality of Recovery After Laparoscopic Partial Nephrectomy

Nerve Block, Nephrectomy, Analgesia

China
Cui Xulei

Completed

TQLB for Postoperative Pain After Laparoscopic Partial Nephrectomy

Pain Management | Laparoscopic Renal Surgery | Nerve Block

China
Cui Xulei

Completed

CTPVB for Hepatectomy

Hepatectomy | Pain Management | Paravertebral Block

China
Cui Xulei

Completed

Quadratus Lumborum Block : Effect on Acute Pain and Quality of Recovery After Laparoscopic Renal Surgery

Pain Management | Laparoscopic Renal Surgery | Nerve Block

China
Xuejie Jiang

Recruiting

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

Leukemia, Myeloid

China
CTI BioPharma

Completed

Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)

Acute Myelogenous Leukemia

United States
CTI BioPharma

Completed

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant (PIX-R)

Diffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 Lymphoma

United States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
CTI BioPharma

Terminated

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. (PIONEER)

NSCLC

United States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
CTI BioPharma

Terminated

Arsenic Trioxide in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
CTI BioPharma

Terminated

Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Lung Cancer

Canada, United States
CTI BioPharma

Terminated

Pacritinib Versus Best Available Therapy to Treat Myelofibrosis

Primary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

United States, Australia, Belgium, Czechia, France, Germany, Hungary, Italy, Netherlands, New Zealand, Russian Federation, United Kingdom
CVI Pharmaceuticals

Unknown

Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia

Hyperlipidemia

China
CTI BioPharma

Completed

A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin (RAPID)

Diffuse Large-Cell Lymphoma

United States, Germany, Canada, Italy, France
CTI BioPharma

Completed

Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer

Colorectal Cancer

Italy
Ling Cui

Completed

Fast-track Surgery After Gynecological Oncology Surgery

Postoperative Complications | Length of Stay | CRP

China
jiuwei cui

Unknown

Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia

Leukemia, B-Cell
CTI BioPharma

Terminated

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

COVID-19 | COVID | COVID19

United States

Clinical Trials Sponsored by Cui xuejun

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations